Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 2009, p. 814-817, Vol. 53, No. 2
0066-4804/09/$08.00+0 doi:10.1128/AAC.01132-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033,1 Laboratory Specialists, Inc., Cleveland, Ohio 44106,2 Chaperone Technologies, Inc., East Stroudsburg, Pennsylvania 183013
Received 22 August 2008/ Returned for modification 22 October 2008/ Accepted 5 November 2008
Synergy time-kill testing of levofloxacin alone and in combination with CHP-105, a representative DnaK inhibitor, against 50 gram-negative rods demonstrated that 34 of the 50 strains tested showed significant synergy between levofloxacin and CHP-105 after 12 h and 24 h. Fourteen of these 34 organisms were quinolone resistant (levofloxacin MICs of
4 µg/ml).
Published ahead of print on 17 November 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»